Point of Care Applications


Dermaflow technology for Home and Clinic

Dermaflow technology (DF) has been validated in the measurement of peripheral blood flow in a variety of clinical applications, including peripheral artery disease (PAD).
Recent pilot clinical work has confirmed earlier trials in demonstrating the ability of the technology to differentiate between PAD-affected and healthy lower limbs.
In this trial, lower limb peripheral blood flow was stimulated using Transcutaneous Electrical Nerve Stimulation (TENS), which is a known effect of this technology.


The advantages of a TENS-DF combination are evident in a variety of point-of-care lower limb peripheral blood flow applications, including:

(1) Mobility compromised individuals: research in PAD patients over 65 years of age has shown that lower limb pain in the largest barrier to increasing mobility.

  • A TENS with Dermaflow Inside™ (TENS-DF) would offer  patients the ability to increase mobility accompanied by a technology which:
    • will monitor their progress,
    • feedback the information
    • facilitate modulation and automation where blood flow is stimulated only when necessary

(2)  PAD screening

  • The TENS-DF combination will allow simple non-invasive screening of asymptomatic individuals, as is shown in the above chart. There is clear difference between peripheral blood flow in PAD-affected and healthy lower limbs..

(3)  Self-monitoring of lower limb peripheral blood flow, for both asymptomatic and PAD affected patients.

  • Increasing sedentary lifestyles increase the risk of PAD

“In a large population-based study, higher levels of physical activity were independently associated with lower odds of vascular disease in the lower extremities and carotid arteries

(Stein et al Arteriosclerosis, Thrombosis, and Vascular Biology. 2015;35:206-212)

  • Use of a TENS-DF can decrease the user probability for development of pre-symptomatic PAD.
  • PAD-diagnosed patients would be able to track the  their conditions in their homes towards disease maintenance and improvement.